A prospective study to assess the impact of pharmacist-led patient-centered interventions in schizophrenia - NI

Dr Deepak C G0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Patient or caretaker
•Patient or caretaker willing to provide informed consent
•Patients aged Ã¢â?°Â¥ 18 and Ã¢â?°Â¤ 65 years old
•Patients diagnosed with schizophrenia and schizophrenia spectrum disorders who were on the treatment of antipsychotic drugs with or without co-morbidities of hypertension, diabetes, hypercholesterolemia and weight gain
•Both genders

•Patient or caretaker unwilling to provide consent
•Patients with other severe chronic medical conditions, including cancer, end-stage renal disease, heart failure and HIV
•Patients with a diagnosis of Cushing syndrome, hypothyroidism, eating disorder
•Patients who are engaged in the weight management programs within the past 3 months
•Patients who are taking other forms of medicines to control weight including Ayurvedha, Homeopathy
•Patients with co-existing physical illnesses that reduce their ability to participate in the study

发起方

Dr Deepak C G